PI22 Hidden Danger in Skin Care Products

Rachel Moseley, MS, RN, CWON, Johns Hopkins Bayview Medical Center, Baltimore, MD
Clinical Purpose/Rationale

There is growing concern about the ingredients contained in some popular healthcare skin care products such as cleansers, lotions and skin barriers. These ingredients include potential hormone disruptors, irritants, and suspected carcinogens. Many of these ingredients are banned in countries with stricter regulations and safety standards. Skin care products are often pooled together with cosmetics and the FDA does not have the authority to require a manufacturer to submit safety information, thus the burden is on the FDA to determine that an ingredient is unsafe, rather than determining safety on the front end. Only a few ingredients are currently restricted for use in the United States1.

Objectives

A review of the literature and independent databases show several chemicals and ingredients that are concerning. Among these are the following types of chemicals: formaldehyde releasing, various fragrances, parabens, triclosans, and phthalates2. It is unknown exactly how much topical ingredients are absorbed systemically, but the potential harms range from irritation to tumorigenic.

Methodology Result

The ingredients lists for common skin care products was analyzed and data compiled to determine which products are likely to be the safest options. This information was provided to the health system value analysis group. Some products were eliminated from consideration for use based upon findings. The facility is developing an Environmental Purchasing Policy that includes a list of questions to consider.

Discussion/Conclusion

As WOC nurses, we work diligently to provide optimal care to our patients by recommending the best cleansers, moisturizers and barrier creams. We often focus on the active ingredients, and neglect to consider the other inactive ingredients. The products we use may be effective in a clinical sense, but we must also consider potential harm to our patients. Selecting the safest, clinically acceptable products will benefit all and encourage manufacturers to reconsider their formulations.